Propanc Biopharma (PK) Stock Quote PPCB - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.0008

Bid

0.0007

Ask

0.0008

Volume

5,024,867

0.0007 Day's Range 0.0008

0.0006 52 Week Range 0.1222

Market Cap

1.312M

Previous Close

0.00075

Open

0.0007

Last Trade

500000

0.0008

Last Trade Time

Financial Volume

$ 3,803

VWAP

0.000757

Average Volume (3m)

27,220,152

Shares Outstanding

1,748,960,531

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

-0

Revenue

Net Profit

-3.13M

Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proe... Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body's primary defense against cancer. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Wilmington, Delaware, USA

Founded

1970

Propanc Biopharma Inc (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PPCB. The last closing price for Propanc Biopharma (PK) was $0. Over the last year, Propanc Biopharma (PK) shares have traded in a share price range of $ 0.0006 to $ 0.1222.

Propanc Biopharma (PK) currently has 1,748,960,531 shares outstanding. The market capitalization of Propanc Biopharma (PK) is $1.31 million. Propanc Biopharma (PK) has a price to earnings ratio (PE ratio) of 0.00.

Biopharma on a Tear After Certificate of Grant from Japanese Patent Office

This biopharma is developing novel cancer treatments for patients suffering from recurring and metastatic cancer. Shares were trading up after the firm announced that a Certificate of Grant for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.00015	-15.7894736842	0.00095	0.001	0.0007	20970903	0.00080195	CS
4	-0.0006	-42.8571428571	0.0014	0.0018	0.0007	26590357	0.00116135	CS
12	-0.00035	-30.4347826087	0.00115	0.0037	0.0006	27220152	0.00137081	CS
26	-0.0094	-92.1568627451	0.0102	0.0102	0.0006	14497815	0.00160726	CS
52	-0.0892	-99.1111111111	0.09	0.1222	0.0006	7623760	0.00263886	CS
156	-41.9992	-99.9980952381	42	52	0.0006	18578627	1.3303752	CS
260	-1609.9992	-99.9999503106	1610	2570	0.0006	13482449	2.33279901	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SHIMShimmick Corporation	$ 3.07 (48.31%)	827.65k
APVOAptevo Therapeutics Inc	$ 0.462 (37.91%)	12.46M
MLGOMicroAlgo Inc	$ 3.72 (30.99%)	2.54M
CAUDCollective Audience Inc	$ 0.56 (24.86%)	100
CEROCERo Therapeutics Holdings Inc	$ 0.2369 (21.49%)	1.36M
CNVSCineverse Corporation	$ 0.71 (-20.22%)	400
FIVEFive Below Inc	$ 87.10 (-14.67%)	14.03k
LCFYLocafy Ltd	$ 4.85 (-11.01%)	10.17k
TANHTantech Holdings Ltd	$ 0.5347 (-10.73%)	6.05k
ESPREsperion Therapeutics Inc	$ 2.44 (-10.62%)	120.79k
APVOAptevo Therapeutics Inc	$ 0.462 (37.91%)	12.46M
MLGOMicroAlgo Inc	$ 3.72 (30.99%)	2.54M
NVDANVIDIA Corporation	$ 122.41 (-3.13%)	1.93M
SQQQProShares UltraPro Short QQQ	$ 7.735 (3.69%)	1.43M
CEROCERo Therapeutics Holdings Inc	$ 0.2369 (21.49%)	1.36M